The Worldwide Virtual Clinical Trials Industry is Expected to Reach $10 Billion by 2026
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Virtual Clinical Trials Market size is expected to reach $10 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. Virtual Clinical Trials (VCTs) are also known as remote or decentralized trails, are a comparatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Europe Virtual Clinical Trials Market (2020 to 2026) - by Study Type, Indication and Country - ResearchAndMarkets.com
February 16, 2021 GMT
DUBLIN (BUSINESS WIRE) Feb 16, 2021
ADVERTISEMENT
Another name for virtual trials is decentralized trials. Virtual trials have a major role to play in the current COVID-19 pandemic and are likely to be a rule in the ways trials and real-world research are run. A virtual technique permits people to participate in the trial from the comfort of their homes which ensures that studies can be continued even when site visits are not feasible. Furthermore, it is a unique method of gathering secure and effective data from participants of clinical researches.